Clinical trial

Placebo Controlled Trial of Bosentan in Scleroderma Patients

NCT00377455

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE2

Study timeline

Study start (unknown)2006-09-01Date precision: month

Registry last updated2018-05-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Systemic Sclerodermaunresolved

Pulmonary Hypertensionunresolved

Interventions

BosentanDRUG · verified · RxNorm: bosentan

PlaceboDRUG

Sponsors & collaborators

Georgetown Universitylead sponsor

Actelioncollaborator

Mapped research locations

Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00377455 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.